发明名称 MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN TARGET
摘要 The present invention relates to a novel library for the generation of muteins and to novel muteins derived from human lipocalin 2 (Lcn2, hNGAL) and related proteins that bind a given target with detectable affinity. The invention also relates to corresponding nucleic acid molecules encoding such a mutein and to a method for their generation. The invention further relates to a method for producing such a mutein. For example, such muteins may serve to bind and deplete pathological forms of natural biomolecules such as the amyloid beta peptide in Alzheimer's disease or may target the fibronectin extra-domain B, which is associated with tumor neovasculature.
申请公布号 US2017114109(A1) 申请公布日期 2017.04.27
申请号 US201615380168 申请日期 2016.12.15
申请人 Pieris Pharmaceuticals GmbH 发明人 SKERRA ARNE;GEBAUER Michaela;HINZ Dominik;RAUTH Sabine;MATSCHINER Gabriele;HUELSMEYER Martin
分类号 C07K14/47;A61K38/17 主分类号 C07K14/47
代理机构 代理人
主权项 1. A mutein derived from human neutrophil gelatinase-associated lipocalin (hNGAL), comprising a mutated amino acid residue at one or more amino acid sequence positions selected from the group consisting of amino acid sequence positions 96, 100, and 106 of mature hNGAL (SEQ ID NO:44) and at nine or more amino acid sequence positions selected from the group consisting of amino acid sequence positions 36, 40, 41, 49, 52, 68, 70, 72, 73, 77, 79, 81, 103, 125, 127, 132, and 134 of mature hNGAL (SEQ ID NO:44), and wherein the mutein binds a given non-natural target with detectable affinity.
地址 Freising-Weihenstephan DE